These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17580050)

  • 1. [Prevalence of atrial fibrillation in the Spanish population aged 60 years or more. The PREV-ICTUS study].
    Cea-Calvo L; Redón J; Lozano JV; Fernández-Pérez C; Martí-Canales JC; Llisterri JL; González-Esteban J; Aznar J;
    Rev Esp Cardiol; 2007 Jun; 60(6):616-24. PubMed ID: 17580050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and estimated risk of stroke in the elderly population of Spain: the PREV-ICTUS study.
    Redón J; Cea-Calvo L; Lozano JV; Martí-Canales JC; Llisterri JL; Aznar J; González-Esteban J;
    Stroke; 2007 Apr; 38(4):1167-73. PubMed ID: 17322073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study].
    Martín-Rioboó E; García Criado E; Pérula De Torres LA; Cea-Calvo L; Anguita Sánchez M; López Granados A; Ureña Fernández T; García Matarín L; Molina Díaz R;
    Med Clin (Barc); 2009 Feb; 132(7):243-50. PubMed ID: 19248873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of atrial fibrillation in Spain. OFRECE study results.
    Gómez-Doblas JJ; Muñiz J; Martin JJ; Rodríguez-Roca G; Lobos JM; Awamleh P; Permanyer-Miralda G; Chorro FJ; Anguita M; Roig E;
    Rev Esp Cardiol (Engl Ed); 2014 Apr; 67(4):259-69. PubMed ID: 24774588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study.
    Clua-Espuny JL; Lechuga-Duran I; Bosch-Princep R; Roso-Llorach A; Panisello-Tafalla A; Lucas-Noll J; López-Pablo C; Queralt-Tomas L; Giménez-Garcia E; González-Rojas N; Gallofré López M
    Rev Esp Cardiol (Engl Ed); 2013 Jul; 66(7):545-52. PubMed ID: 24776203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of atrial fibrillation and relationed factors in a population in the centre Madrid].
    Candel FJ; Matesanz M; Cogolludo F; Candel I; Mora C; Bescos T; Martín M; Vila i Costa I
    An Med Interna; 2004 Oct; 21(10):477-82. PubMed ID: 15511197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Permanent atrial fibrillation in heart disease in Spain. The CARDIOTENS study 1999].
    García-Acuña JM; González-Juanatey JR; Alegría Ezquerra E; González Maqueda I; Listerri JL
    Rev Esp Cardiol; 2002 Sep; 55(9):943-52. PubMed ID: 12236924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation.
    Proietti M; Marra AM; Tassone EJ; De Vuono S; Corrao S; Gobbi P; Perticone F; Corazza GR; Basili S; Lip GY; Violi F; Raparelli V; ;
    Am J Cardiol; 2015 Sep; 116(6):877-82. PubMed ID: 26183791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between rs2200733 and rs7193343 genetic variants and atrial fibrillation in a Spanish population, and meta-analysis of previous studies.
    Ferrán A; Alegret JM; Subirana I; Aragonès G; Lluis-Ganella C; Romero-Menor C; Planas F; Joven J; Elosua R
    Rev Esp Cardiol (Engl Ed); 2014 Oct; 67(10):822-9. PubMed ID: 25262128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The etiology and associated risk factors in a sample of 300 patients with atrial fibrillation].
    Barriales Alvarez V; Morís de la Tassa C; Sánchez Posada I; Barriales Villa R; Rubin López J; de la Hera Galarza JM; Vara Manso J; Hevia Nava S; Cortina Llosa A
    Rev Esp Cardiol; 1999 Jun; 52(6):403-14. PubMed ID: 10373774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint study.
    Bang CN; Okin PM; Køber L; Wachtell K; Gottlieb AB; Devereux RB
    J Hypertens; 2014 Mar; 32(3):667-72. PubMed ID: 24379001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older.
    Morillas P; Pallarés V; Fácila L; Llisterri JL; Sebastián ME; Gómez M; Castilla E; Camarasa R; Sandin M; García-Honrubia A;
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):485-91. PubMed ID: 25487320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.
    Ostgren CJ; Merlo J; Råstam L; Lindblad U
    Diabetes Obes Metab; 2004 Sep; 6(5):367-74. PubMed ID: 15287930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients.
    Genovesi S; Pogliani D; Faini A; Valsecchi MG; Riva A; Stefani F; Acquistapace I; Stella A; Bonforte G; DeVecchi A; DeCristofaro V; Buccianti G; Vincenti A
    Am J Kidney Dis; 2005 Nov; 46(5):897-902. PubMed ID: 16253730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
    de Lusignan S; van Vlymen J; Hague N; Thana L; Dzregah B; Chan T
    J Public Health (Oxf); 2005 Mar; 27(1):85-92. PubMed ID: 15590708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus is an independent risk factor for atrial fibrillation in a general Chinese population.
    Sun G; Ma M; Ye N; Wang J; Chen Y; Dai D; Sun Y
    J Diabetes Investig; 2016 Sep; 7(5):791-6. PubMed ID: 27180678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial.
    Morillas P; Pallarés V; Llisterri JL; Sanchis C; Sánchez T; Fácila L; Pérez-Alonso M; Castillo J; Redón J; Bertomeu V;
    Rev Esp Cardiol; 2010 Aug; 63(8):943-50. PubMed ID: 20738939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.
    Verdecchia P; Dagenais G; Healey J; Gao P; Dans AL; Chazova I; Binbrek AS; Iacobellis G; Ferreira R; Holwerda N; Karatzas N; Keltai M; Mancia G; Sleight P; Teo K; Yusuf S;
    J Hypertens; 2012 May; 30(5):1004-14. PubMed ID: 22495138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors.
    Wilhelmsen L; Rosengren A; Lappas G
    J Intern Med; 2001 Nov; 250(5):382-9. PubMed ID: 11887972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
    Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
    Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.